D.E. Shaw & Co
PLSE icon

D.E. Shaw & Co’s Pulse Biosciences PLSE Stock Holding History

D.E. Shaw & Co’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.27M Buy
81,818
+68,092
+496% +$1.61M ﹤0.01% 3090
2026
Q1 		$296K Buy
+13,726
New +$253K ﹤0.01% 4077
2022
Q3 		– Sell
-31,827
Closed -$49K – 5448
2022
Q2 		$49K Sell
31,827
-69,189
-68% -$174K ﹤0.01% 4845
2022
Q1 		$491K Buy
+101,016
New +$827K ﹤0.01% 4379
2021
Q3 		– Sell
-17,528
Closed -$287K – 5161
2021
Q2 		$287K Buy
+17,528
New +$334K ﹤0.01% 4304
2021
Q1 		– Sell
-12,391
Closed -$296K – 4397
2020
Q4 		$296K Buy
+12,391
New +$197K ﹤0.01% 3605

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

D.E. Shaw & Co's PLSE Position: Q2 2026 in Review

D.E. Shaw & Co increased its Pulse Biosciences (PLSE) stake by 496% in Q2 2026, buying an estimated $1.61M and bringing the position to 81,818 shares worth $2.27M. The position accounts for ﹤0.01% of the portfolio, ranked #3090.

D.E. Shaw & Co first reported a position in PLSE in Q4 2020 and has held it in 6 quarters since. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • D.E. Shaw & Co held 81,818 shares of Pulse Biosciences worth $2.27M as of Q2 2026.
  • D.E. Shaw & Co bought 68,092 Pulse Biosciences shares in Q2 2026, an estimated $1.61M.
  • Pulse Biosciences made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #3090 holding.
  • D.E. Shaw & Co first reported a position in Pulse Biosciences in Q4 2020 and has held it in 6 quarters since.
  • 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.